HomeCompareOSRS vs JNJ

OSRS vs JNJ: Dividend Comparison 2026

OSRS yields 5000000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 OSRS wins by $4.651129742658086e+43M in total portfolio value
10 years
OSRS
OSRS
● Live price
5000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.651129742658086e+43M
Annual income
$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00
Full OSRS calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — OSRS vs JNJ

📍 OSRS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOSRSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OSRS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OSRS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OSRS
Annual income on $10K today (after 15% tax)
$425,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, OSRS beats the other by $39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OSRS + JNJ for your $10,000?

OSRS: 50%JNJ: 50%
100% JNJ50/50100% OSRS
Portfolio after 10yr
$2.325564871329043e+43M
Annual income
$23,254,733,801,667,206,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
100.00%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

OSRS
No analyst data
Altman Z
0.4
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OSRS buys
0
JNJ buys
0
No recent congressional trades found for OSRS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOSRSJNJ
Forward yield5000000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$4.651129742658086e+43M$30.3K
Annual income after 10y$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00$4,689.40
Total dividends collected$4.651117771440442e+43M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: OSRS vs JNJ ($10,000, DRIP)

YearOSRS PortfolioOSRS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$500,010,700$500,000,000.00$10,592$272.30+$500.00MOSRS
2$23,365,520,992,757$23,364,985,981,308.41$11,289$357.73+$23365520.98MOSRS
3$1,020,442,548,175,215,100$1,020,417,547,067,752,800.00$12,123$472.89+$1020442548175.20MOSRS
4$41,650,346,151,752,480,000,000$41,649,254,278,225,940,000,000.00$13,141$629.86+$41650346151752480.00MOSRS
5$1,588,787,048,835,084,000,000,000,000$1,588,742,482,964,701,800,000,000,000.00$14,408$846.81+$1.588787048835084e+21MOSRS
6$56,640,860,400,245,200,000,000,000,000,000$56,639,160,398,102,940,000,000,000,000,000.00$16,021$1,151.60+$5.66408604002452e+25MOSRS
7$1,887,170,449,619,629,000,000,000,000,000,000,000$1,887,109,843,899,000,500,000,000,000,000,000,000.00$18,122$1,588.22+$1.887170449619629e+30MOSRS
8$58,763,764,792,023,670,000,000,000,000,000,000,000,000$58,761,745,519,642,570,000,000,000,000,000,000,000,000.00$20,930$2,228.20+$5.876376479202367e+34MOSRS
9$1,710,115,183,602,138,000,000,000,000,000,000,000,000,000,000$1,710,052,306,373,811,000,000,000,000,000,000,000,000,000,000.00$24,792$3,191.91+$1.710115183602138e+39MOSRS
10$46,511,297,426,580,864,000,000,000,000,000,000,000,000,000,000,000$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00$30,274$4,689.40+$4.651129742658086e+43MOSRS

OSRS vs JNJ: Complete Analysis 2026

OSRSStock

Osiris Corporation, through its subsidiaries, manufactures and distributes industrial and construction equipment. The company offers a line of skid steer and mini skid steer loaders, rough terrain forklifts, and telescopic handlers, as well as attachments, mortar/plaster mixers, mortar boxes, buggies, mobile screening plants, and six models of mini excavators. It distributes its products through a network of distributors, wholesalers, and private label partnerships, as well as through direct sales offices. In addition, it manufactures specialty industrial and construction products, a line of potato harvesting and handling equipment, fluid power components, pneumatic and hydraulic systems, spiral wound metal gaskets, and packing material. It offers its products to customers in the pulp and paper, aluminum plant, forestry equipment, automotive, oil and gas, heavy equipment, hydraulics, injection molding, and power generation industries. The company was formerly known as Thomas Equipment, Inc. and changed its name to Osiris Corporation in January 2008. Osiris Corporation was founded in 1943 and is based in Baldwin, New York. Osiris Corporation is a former subsidiary of McCain Foods Limited.

Full OSRS Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this OSRS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OSRS vs SCHDOSRS vs JEPIOSRS vs OOSRS vs KOOSRS vs MAINOSRS vs ABBVOSRS vs MRKOSRS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.